Association of Peri-Procedural Major Bleeding With Outcomes in Patients Undergoing Percutaneous Left Atrial Appendage Closure

Percutaneous left atrial appendage closure (LAAC) with the Watchman device (Boston Scientific, Marlborough, MA) is indicated for reduction of thromboembolic risk in patients with non-valvular atrial fibrillation who are poor candidates for long-term oral anticoagulation. The procedure is performed via femoral venous access using a 14 F sheath. Data from the pivotal randomized controlled trials and real-world clinical practice have shown that major bleeding in the procedural setting remains one of the most common complications of LAAC (1.5% to 3.5%).
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research